Gallbladder-colic hepatic flexure adhesion syndrome
Cholecysto-hepatic flexure adhesion syndrome was first described by Verbryche in 1930. Therefore, it is also called Verbrycke syndrome and cholecysto-hepatic flexure adhesion syndrome.
-
Site of disease:
Gallbladder and liver -
Infectious :
Not contagious -
Frequent population:
All -
Related symptoms:
Dull pain nausea loss of appetite abnormal appetite stomach ache -
Concurrent disease:
Related Drugs
Aprotinin for injection
Indication: Used for open heart surgery with extracorporeal circulation or other surgeries. Inhibits fibrinolytic protein, reduces intraoperative and postoperative bleeding and postoperative intestinal adhesion.
Manufacturer:
Jilin Aodong--Taonan Pharnalentical Company Ltd
Shilintong Tablets
Manufacturer:
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
Aprotinin for injection
Indication: Used for open heart surgery with extracorporeal circulation or other surgeries. Inhibits fibrinolytic protein, reduces intraoperative and postoperative bleeding and postoperative intestinal adhesion.
Manufacturer:
Jilin Aodong--Taonan Pharnalentical Company Ltd